No abstract

No abstract

L´insuffisance rénale terminale nécessite un traitement de suppléance notamment l´hémodialyse. Avant l´initiation, le patient et son entourage reçoivent des informations sur la maladie rénale et les possibilités de traitement. Ce travail a pour objectif d´évaluer le niveau de connaissance ainsi que l´opinion de l´hémodialysé et de son entourage sur la maladie rénale chronique et les traitements de suppléances rénales. Il s´est agi d´une étude transversale descriptive qui s´est déroulée du 29 juillet au 19 août 2020 dans l´unité d´hémodialyse du CHU-SO. La population de notre étude était constituée de tous les patients hémodialysés de l´unité d´hémodialyse du CHU-SO et de leurs accompagnants qui ont donné leur consentement libre et éclairé. Les données ont été collectées de façon anonyme à partir d´un questionnaire. La saisie et l´analyse statistique des données ont été faites au moyen du logiciel Epi Info dans sa version 7.2.2.6. Quatre-vingt-et-un patients et 79 accompagnants ont été interrogés. Les âges moyens des patients et leur accompagnant étaient respectivement de 49,7 ans ± 13,5 et 39,6 ans ± 13,2. Tous les patients connaissaient leur pathologie et 94% des accompagnants, les informations sur la maladie de leurs parents. L´hémodialyse était considérée très chère par 95,1% des patients. L´avantage de l´hémodialyse le plus connu par les patients était la qualité de vie améliorée (80,2%) et 15% pensaient également que la transplantation rénale était tout aussi efficace. La majorité des accompagnants (85%) ont déclaré que l´hémodialyse était le meilleur traitement. L´éducation thérapeutique des patients hémodialysés et des accompagnants est importante pour une meilleure prise en charge globale des hémodialysés.

Background: Acute kidney injury (AKI) is one of the increasingly described complications of coronavirus infection. Objectives: To identify factors associated with death in patients with acute kidney injury (AKI) during Coronavirus disease (COVID-19) in Abidjan, Côte d'Ivoire. Material and Method: This was a monocentric retrospective analytical study of all patients over 18 years of age with AKI during COVID-19 at the Farah Polyclinic in Abidjan, Côte d'Ivoire. AKI was defined and ranked according to Kidney Disease Improving Global Outcomes (KDIGO) 2012. The data were collected from the medical record and processed using RStudio. Results: Forty-three cases were collected. The average age was 58.5 12 years. The sex ratio (M/F) was 4.4. The main comorbidities were high blood pressure (60.4%) and diabetes (37.2%). AKI was at KDIGO stage 3 in 58%, KDIGO 2 in 21% and KDIGO 1 in 21%. The diagnosis of acute tubular necrosis was retained in 44.2% of patients followed by acute functional kidney injury in 32.6%. Hemodialysis was initiated in 48.8% of cases. The main indication of dialysis was anuria (46.6%). In total, 55.8% of patients died. Factors associated with death were KDIGO stage (p = 0.049), and invasive ventilation (p < 0.001) associated with the risk of death in univariate analysis. Conclusion: Mortality is high in patients with AKI during COVID-19 infection.

Objective: To describe the epidemiological, clinical and evolutionary profile of ADPKD in Togo. Methods: A retrospective descriptive transversal study over a period of 8 years (2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018) which focused on the analysis of patients' records diagnosed with ADPKD. The diagnosis of ADPKD was retained on the basis of the ultrasound criteria of PEI. Results: During the study period, 27 patients had polycystic kidney disease with a prevalence of 0.87%. The average age was 51.6 ± 16.4 years. There were 10 men (37%) and 17 women (63%), a sex ratio (M/F) of 0.58. The concept of family cystic kidney disease was found in 6 (22.2%) patients. The clinical presentations were dominated by arterial high blood pressure, abdominal pain and abdominal mass respectively in 77%, 63% and 63% of cases. Five patients (18.5%) had a glomerular filtration rate (GFR) greater than 90 ml/min, 17 (62.9%) had a GFR < 60 ml/min. All patients (100%) had multiple renal cysts, 16 patients (59.3%) had dedifferentiated kidneys. Six patients (22.2%) had liver cysts, one patient (3.7%) had lithiasis. Genetic was not achieved because of the poor technical platform and the high cost of these tests. Conclusion: ADPKD is common in our department. It appears to be associated with a high rate of chronic renal failure.